Clinical TrialsSearch results
Number of results: 1068
No Longer Recruiting
- Feasibility trial of UFT after withdrawal of adjuvant TS-1 with adverse effects in patients with curatively resected gastric cancer.
- Gastric Cancer
- Division of Gastrointestinal Surgery, Kobe University Hospital
- 2008-05-07
No Longer Recruiting
- Study of diagnostic procedure of acute cellular rejection(ACR) using bile in liver transplantation
- Liver transplant recipients
- Osaka university graduate school of medicine Department of gastroenterological surgery
- 2009-07-15
No Longer Recruiting
- TCD-11226
- Residual aortic dissection (including pseudoaneurysm at the anastomotic site) after ascending aortic
- Sugisaki Shunichiro
- 2023-06-21
Recruiting
- [M24-305]Atogepant for the Acute Treatment of Migraine
- Migraine
- Otani Tetsuya
- 2024-04-03
Recruiting
- A clinical trial of the effect of remimazolam on postoperative ECG in gynecologic laparotomy
- Patients scheduled for gynecologic laparotomy
- Hori Kotaro
- 2022-07-26
Recruiting
- A Japanese prospective observational study to assess a correlation between pre-surgical analysis of ctDNA and post-surgical pathological upstaging in patients with resectable clinical stage IA-IB Non-Small Cell Lung Cancer (NSCLC)
- Resectable clinical stage IA-IB Non-Small Cell Lung Cancer(NSCLC)
- Hibi Kazushige
- 2024-03-06
Recruiting
- A multicenter randomized controlled trial of the efficacy of anti-adhesion barrier in laparoscopic rectal amputation
- rectal cancer, rectal neuroendocrine tumor
- Uemura Mamoru
- 2024-05-20
Recruiting
- A multicenter single-arm P2 to evaluate safety and efficacy of the total neoadjuvant therapy for cT2 rectal cancer.
- rectal cancer
- Uemura Mamoru
- 2023-04-13
Recruiting
- A multicenter, pivotal study to demonstrate non-inferiority of Cyt-006 compared to Seprafilm in patients with primary rectal cancer and temporal colostomy underwent laparoscopic surgery
- primary rectal cancer
- Horii Yoshihiro
- 2022-08-10
Recruiting
- A Multicenter, Randomized, Parallel-group, Double-blind,Two-arm Phase III Study to Evaluate the Safety and Efficacy of Anifrolumab Compared With Placebo in Male and Female Participants 18 to 70 Years of Age Inclusive With Systemic Sclerosis
- Systemic Sclerosis, Scleroderma
- Ageishi Yuji
- 2023-11-11